Lusutrombopag Combined With Recombinant Human Thrombopoietin for the Treatment of Thrombocytopenia in Patients With Chronic Liver Disease Destined to Undergo Elective Invasive Surgery

NCT06673498 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

60

Enrollment

OTHER_GOV

Sponsor class

Conditions

Thrombocytopenia

Interventions

DRUG: Lusutrombopag combined with recombinant human thrombopoietin

Sponsor

Anhui Provincial Hospital